Skip to content
Brand AI

Haisco Pharmaceutical Group Co., Ltd.

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2020

    Haisco warned by Tibet CSRC branch over governance, related-party guarantee disclosure

    The Tibet branch of the CSRC said Haisco had non-standard corporate governance, delayed disclosure of related-party transactions and guarantees, and incomplete insider registration, and issued warning letters recorded in integrity files; reports also said its performance relied heavily on government subsidies. Warning letters.

    Source